BioSpace News Archive

CoolX1000 Series Provides New Level of Flexibility in Power Supply Monitoring and Control Through Analog and Digital Communications

Impressive 12-Month Patient Outcomes from SONATA Pivotal IDE Trial Being Highlighted

Graham-Pelton Consulting, the American Psychiatric Association Foundation, and Fenton will host a timely panel discussion examining how nonprofits, corporations, and foundations can drive critical change in society through philanthropy on Tuesday, November 13, 2018 at 8:30 a.m. at The National Press Club,

Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an agreement with Amneal Pharmaceuticals, Inc. (Amneal) with regard to Levothyroxine Sodium Tablets USP.

Leading researchers from the U.S., U.K., and Europe at a Swiss conference last month reported progress on incriminating several infectious agents as possible triggers of Alzheimer’s disease, says Leslie Norins, MD, PhD, a speaker and CEO of Alzheimer’s Germ Quest, Inc.

AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., US (Merck: known as MSD outside the US and Canada) today announced that the US Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) and granted priority review for the approval of LYNPARZA

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on using the body’s immune system to fight cancer, today announced that its two presentations at the 33rd Annual Meeting of The Society for Immunotherapy of Cancer (SITC) are now available on its website at www.anixa.com.

Renovia Inc. (“Renovia”), a company dedicated to discovering and delivering first-line digital therapeutic and diagnostic devices for women with pelvic floor disorders, today announced it has launched a large, multi-center randomized controlled trial (RCT) to study the efficacy of a first-line non-surgical digital therapeutic for the treatment of stress-dominant urinary incontinence (UI).

Concert Pharmaceuticals, Inc. today announced interim topline results from the first two cohorts of its Phase 2a trial

Stéphane Le Roy has been appointed President Business Area Surgical Workflows and member of the Getinge Executive Team. Stéphane most recently held the position of Regional President of South West Europe, in Getinge.